Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.725    0.00 (0.00%)
Bid:
0.70
Ask:
0.75
Spread: 0.05 (7.143%)
Market Cap: £3.24m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

Director Dealing

12 Dec 2017 16:00

RNS Number : 1344Z
Thruvision Group PLC
12 December 2017
 

12 December 2017

Thruvision Group plc 

 

Director Dealing

Thruvision Group plc (AIM: THRU), ("Thruvision" the "Company" or, together with its subsidiary undertakings, the "Group") the specialist provider of people-screening technology to the global security market, announces that on 11 December 2017, Colin Evans, Managing Director of Thruvision, notified the Board of dealings in ordinary shares in the Company.

On 11 July 2017 Colin Evans' investment manager, HSBC, sold in error without his consent or knowledge;

 

· 108,398 ordinary shares in the Company (held in an ISA in the name of Colin Evans) at a price of 27.5 pence per share, a total of £29,808.95.

 

· 106,968 ordinary shares in the Company (held in an ISA in the name of his wife, Fiona Evans) at a price of 27.5 pence per share, a total of £29,415.70.

 

Following these transactions, Colin Evan's aggregated beneficial total shareholding in the company is 1,359,554 Ordinary Shares representing 0.82% of the Company's current total issued share capital and total voting rights.

 

Colin Evans was notified by HSBC of these transactions on Monday 11 December 2017 and informed the Company immediately. The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail:

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Colin Evans

2.

Reason for the notification

(a)

Position/status

Managing Director

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Thruvision Group plc

(b)

LEI

213800IZG9GM6G2TZE04

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.01 each

(b)

Identification code of the Financial Instrument

GB00B627R876

(c)

Nature of the transaction

Sale of shares

 

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

27.5p

215,366

(e)

Aggregated information

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

11 July 2017

(g)

Place of the transaction

London Stock Exchange

 

 

 

For further information please contact:

 

Thruvision Group plc

Tom Black, Executive Chairman

Colin Evans, Managing Director

 

+44 (0)20 3553 5888

Investec Bank plc (Financial Adviser, NOMAD & Broker)

Andrew Pinder / Sebastian Lawrence / Patrick Robb

 

+44 (0)20 7597 5970

FTI Consulting LLP

Edward Bridges / Matt Dixon / Harry Staight

 

+44 (0)20 3727 1000

 

 

About Thruvision

Thruvision Group plc is a specialist provider of people-screening technology that can safely see weapons, explosives and contraband hidden in peoples' clothing. Developed with extensive support from the British and US Governments, Thruvision technology is operationally proven and is being used to enhance the security of transport hubs, borders, high profile buildings and public areas.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBUBDDRUBBGRD
Date   Source Headline
31st May 20245:06 pmRNSHolding(s) in Company
30th May 20247:00 amRNSThruvision partners with Sensormatic Solutions
22nd May 202412:26 pmRNSBlock listing Interim Review
22nd May 202412:26 pmRNSBlock listing Interim Review
26th Apr 20247:00 amRNSYear-end trading update
18th Mar 20247:00 amRNSWalkTHRU completes operational test and evaluation
1st Feb 20247:00 amRNSNext generation product range & software launched
26th Jan 20247:00 amRNSSales Progress Update
22nd Jan 20242:48 pmRNSHolding(s) in Company
10th Jan 202410:39 amRNSAward of Share Options to Executive Director
28th Nov 202311:50 amRNSBlocklisting update
28th Nov 202311:48 amRNSBlocklisting update
20th Nov 20237:00 amRNSInterim Results
13th Nov 20238:51 amRNSUK retail theft to cost £7.9bn in 2023
6th Nov 20234:27 pmRNSNotice of Interim Results
27th Oct 202311:32 amRNSHolding(s) in Company
26th Oct 20232:34 pmRNSHolding(s) in Company
26th Oct 20232:23 pmRNSHolding(s) in Company
25th Oct 202312:04 pmRNSHolding(s) in Company
24th Oct 20237:00 amRNSResult of placing
23rd Oct 20234:35 pmRNSLaunch of placing
2nd Oct 20237:00 amRNSHalf year trading update
21st Sep 202311:12 amRNSResult of Annual General Meeting
22nd Aug 202311:56 amRNSAward of Share Options to Executive Directors
21st Jul 20237:00 amRNSResults for the year ended 31 March 2023
13th Jul 20235:09 pmRNSNotice of Results
7th Jun 20237:00 amRNSBlocklisting update
7th Jun 20237:00 amRNSBlocklisting update
21st Apr 20237:00 amRNSYear end trading update
3rd Feb 20237:00 amRNSSharesave option grant to Executive Director
12th Jan 202310:24 amRNSChange of Auditor
21st Dec 20227:00 amRNSDirector Share Dealing
19th Dec 20227:00 amRNSInterim Results
15th Dec 20227:00 amRNSCORRECTION - Blocklisting Update
13th Dec 20227:00 amRNSBlocklisting Update
13th Dec 20227:00 amRNSBlocklisting Update
30th Nov 20227:00 amRNSNotice of Results
9th Nov 20227:00 amRNSAward of Share Options to Executive Directors
8th Nov 20222:50 pmRNSHolding(s) in Company
26th Oct 202211:50 amRNSResult of AGM
12th Oct 20227:00 amRNSH1 Trading Update
3rd Oct 20227:00 amRNSCBP Framework Agreement and Contract Award
30th Sep 20227:00 amRNSResults for the Year ended 31 March 2022
22nd Sep 20223:00 pmRNSContract Award, Trading Update, Notice of Results
16th Jun 20227:00 amRNSAppointment of Chief Financial Officer
15th Jun 20228:31 amRNSHolding(s) in Company
8th Jun 20223:32 pmRNSBlocklisting update
8th Jun 20223:30 pmRNSBlocklisting update
6th May 202212:12 pmRNSDirector Share Dealing-correction & further trade
20th Apr 20227:00 amRNSDirector Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.